Toxicology studies determine the and identify potential organs of toxicity, providing a baseline safety profile required by regulatory bodies like the FDA before human trials can begin. 4. Clinical Development: Testing in Humans
Pharmacology is the bedrock of modern medicine. It is the science of how drugs interact with biological systems—specifically, what a drug does to the body (pharmacodynamics, or PD) and what the body does to the drug (pharmacokinetics, or PK). Without pharmacology, drug discovery would be random screening, and drug development would lack a rational framework for safety and efficacy. This write-up outlines how pharmacology guides every stage of the journey from a molecule to a marketed medicine.
Machine learning models (graph neural networks) trained on millions of known drug-target interactions can now predict: pharmacology in drug discovery and development
PK tracks the life cycle of a compound within the system. It is commonly summarized by the acronym ADME : Absorption: How the drug enters the bloodstream. Distribution: How it travels to various tissues and organs.
Determining how the drug is distributed to the target tissues. It is the science of how drugs interact
Looking ahead, the future of pharmacology in drug discovery is undeniably . The goal is to move beyond describing what a drug does to being able to accurately predict its behavior in humans based on preclinical data. This is being achieved through the creation of sophisticated mathematical models that can integrate vast amounts of data—from molecular structure to PK/PD parameters to omics data from patients—to forecast a drug's effects in a virtual human.
Before any new drug can be tested in humans, it must undergo a rigorous battery of nonclinical (preclinical) safety studies. This is a primary responsibility of pharmacology and toxicology, aimed at answering: The goal is to identify potential safety risks and to characterize the compound's pharmacological and toxicological profile. These studies are governed by Good Laboratory Practice (GLP) regulations to ensure data quality and integrity. Machine learning models (graph neural networks) trained on
Pharmacologists work to understand the underlying mechanisms of diseases to identify molecular targets, such as enzymes, receptors, or signaling pathways, which can be modified by a drug [5.2]. Target validation involves establishing that manipulating a specific target indeed produces a therapeutic effect. Screening and Optimization
How the drug travels through fluids and tissues to reach its target site.
Toxicology studies determine the maximum tolerated dose and identify potential long-term risks like carcinogenicity (cancer-causing potential) or genotoxicity (DNA damage). 4. Clinical Development: Testing in Humans